Loading insider details...
Latest Form 4 (Jun 30, 2026): Grant/Award of 15,000 SEPN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 30, 2026 | Septerna, Inc. (SEPN) | Grant/Award | 15,000 | n/a |
| Jun 13, 2026 | Janux Therapeutics, Inc. (JANX) | Grant/Award | 5,500 | n/a |
| Jun 11, 2026 | Parabilis Medicines, Inc. (PBLS) | Grant/Award | 20,215 | n/a |
| Jun 10, 2026 | Bicara Therapeutics Inc. (BCAX) | Grant/Award | 19,475 | n/a |
| Jun 1, 2026 | Tyra Biosciences, Inc. (TYRA) | Grant/Award | 13,160 | n/a |
| Jun 20, 2025 | Septerna, Inc. (SEPN) | Grant/Award | 16,623 | n/a |
| Jun 13, 2025 | Janux Therapeutics, Inc. (JANX) | Grant/Award | 3,750 | n/a |
| Jun 10, 2025 | Bicara Therapeutics Inc. (BCAX) | Grant/Award | 23,746 | n/a |
| Jun 2, 2025 | Tyra Biosciences, Inc. (TYRA) | Grant/Award | 22,200 | n/a |
| Sep 16, 2024 | Bicara Therapeutics Inc. (BCAX) | Grant/Award | 23,746 | n/a |